Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA Dosing for Major Joint Replacement Surgery
NCT05075200Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Dec 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in postoperative hemorrhage, postoperative anemia, sponsored by Sunnybrook Health Sciences Centre. Started Dec 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhagepostoperative anemia
Beyond the preview
Go deeper on NCT05075200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05075200.